Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Different types of polycystic ovary syndrome show varying levels of insulin resistance, with the 'PHO' type being the most insulin resistant.

Statins can reduce androgen levels and improve symptoms in women with PCOS.

Blocking a specific enzyme might help treat obesity and diabetes, but more research is needed to ensure it's safe.

MVP treatment is effective and safe for recurrent breast cancer.

Vismodegib can cause muscle spasms, taste changes, hair loss, fatigue, weight loss, and possibly new issues like skin cancer, dehydration, and swallowing problems, needing close monitoring.

New treatments for vitiligo, including the first FDA-approved option, are improving patient care and quality of life.

Metformin is effective for various skin disorders but may cause skin side effects.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

New treatments for PCOS using smart drug delivery, metabolic changes, and AI show promise but need more research.

Combination therapies might work better for some vitiligo patients, but results vary.

Semaglutide may help some skin disorders but can also cause skin issues.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Spinach-derived thylakoid supplements plus a low-calorie diet helped obese women with polycystic ovary syndrome lose weight and improve their metabolism.

The combination tablet of finasteride and doxazosin works the same as taking each drug separately.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Changes in SHBG levels don't predict diabetes risk reduction.

Advanced therapy medicinal products show promise for vitiligo treatment with fewer side effects, but affordability is a challenge.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.

Finasteride reduced VEGF expression and microvascular density in diabetic mice.

Lifestyle changes and insulin-sensitizing drugs are effective for managing PCOS.

Vitexin shows promise as a cancer treatment by affecting key cellular processes and pathways.

Insulin resistance might not be enough to worsen blood vessel function in young, nonobese women with polycystic ovary syndrome.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.